5 research outputs found
CicatrizaciĂłn meniscal: Estudio experimental en oveja
Las caracterĂsticas vasculares del menisco dificultan la cicatrizaciĂłn en las zonas mĂĄs internas. Para su reconstrucciĂłn es necesario realizar tĂ©cnicas que aumenten el aporte vascular a esa zona. Una de las tĂ©cnicas propuestas es conectar la lesiĂłn interna con la zona perifĂ©rica vascular a travĂ©s de incisiones transversales. En 24 ovejas adultas de raza merina se realizaron incisiones longitudinales en la zona "rojo-blanca" del menisco interno, completĂĄndolos con un trazo transversal comunicado con el paramenisco, procediendo posteriormente a la sutura. Los animales fueron sacrificados a las 3, 6, 12, 26, 32 y 52 semanas, cuatro animales en cada periodo de tiempo. Los meniscos fueron extraĂdos al sacrificio y estudiados con microscopia Ăłptica, tĂ©cnicas de inmunohistoquimia para la colĂĄgena tipo II, y espectometrĂa de absorciĂłn para glicosominoglicanos. La cicatrizaciĂłn fue incompleta en el 91% de los casos en la vertiente anterior de la herida y en el 81% de los casos en la vertiente posterior. La cicatriz inicial era rica en colĂĄgeno II, disminuyendo progresivamente hasta los mismos niveles del tejido meniscal normal. Los glicosominoglicanos aumentaron progresivamente en la cicatriz hasta duplicar los niveles del menisco normal. El estudio histolĂłgico de la cicatrizaciĂłn de la rotura meniscal no confirmaron los aparentes buenos resultados observados en artroscopia.The meniscus healing capacity is obstructed by its poor vascular supply, therefore various proposed techniques enhance vascularity. One of the options is to make a transverse incision to connect the tear with the periphery of the meniscus. Twenty-four mature sheep were operated on making a longitudinal incision in the red-white zone of the medial meniscus. A transverse incision was made connecting the tear with the periphery and then the tear was sutured. Specimens were harvested at 3, 6, 12, 26, 32 and 52 weeks, four animals at each time period. Laboratory analysis included light microscopy, collagen type II content measurement, and absorption spectrophotometry for glicosamin-glycanes. Meniscus healing was incomplete in 91% of the cases at the anterior arm of the tear and in 81% at the posterior arm. At early stages the scar was rich in type II collagen but decreased with time until the levels of a normal meniscus. Glicosamin-glycane content increased to two fold the level of a normal meniscus. Histology did not confirm the good results observed by arthroscopy after meniscal repair
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism
Background Atrial fibrillation (AF) may exist before or occur early in the course of pulmonary embolism (PE). We determined the PE outcomes based on the presence and timing of AF. Methods and Results Using the data from a multicenter PE registry, we identified 3 groups: (1) those with preexisting AF, (2) patients with new AF within 2 days from acute PE (incident AF), and (3) patients without AF. We assessed the 90-day and 1-year risk of mortality and stroke in patients with AF, compared with those without AF (reference group). Among 16 497 patients with PE, 792 had preexisting AF. These patients had increased odds of 90-day all-cause (odds ratio [OR], 2.81; 95% CI, 2.33-3.38) and PE-related mortality (OR, 2.38; 95% CI, 1.37-4.14) and increased 1-year hazard for ischemic stroke (hazard ratio, 5.48; 95% CI, 3.10-9.69) compared with those without AF. After multivariable adjustment, preexisting AF was associated with significantly increased odds of all-cause mortality (OR, 1.91; 95% CI, 1.57-2.32) but not PE-related mortality (OR, 1.50; 95% CI, 0.85-2.66). Among 16 497 patients with PE, 445 developed new incident AF within 2 days of acute PE. Incident AF was associated with increased odds of 90-day all-cause (OR, 2.28; 95% CI, 1.75-2.97) and PE-related (OR, 3.64; 95% CI, 2.01-6.59) mortality but not stroke. Findings were similar in multivariable analyses. Conclusions In patients with acute symptomatic PE, both preexisting AF and incident AF predict adverse clinical outcomes. The type of adverse outcomes may differ depending on the timing of AF onset.info:eu-repo/semantics/publishedVersio
Patient-Level, Institutional, and Temporal Variations in Use of Imaging Modalities to Confirm Pulmonary Embolism
International audienceBackground: The choice of the imaging modality for diagnosis of pulmonary embolism (PE) could be influenced by provider, patient or hospital characteristics, or over time. However, little is known about the choice of the diagnostic modalities in practice. The aim of this study was to evaluate the variations in the use of imaging modalities for patients with acute PE. Methods: Using the data from Registro Informatizado Enfermedad TromboEmbolica (RIETE), a prospective international registry of patients with venous thromboembolism (March 2001âJanuary 2019), we explored the imaging modalities used in patients with acute PE. The imaging modalities included computed tomography pulmonary angiography, ventilation/perfusion scanning, pulmonary angiography, a combination of these tests, or PE signs and symptoms plus imaging-confirmed proximal deep vein thrombosis but no chest imaging. Results: Among 38â025 patients with confirmed PE (53.1% female, age: 67.3±17 years), computed tomography pulmonary angiography was the dominant modality of diagnosis in all RIETE enrollees (78.2% [99% CI, 77.6â78.7]); including pregnant patients (58.9% [99% CI, 47.7%â69.4%]) and patients with severe renal insufficiency (62.5% [99% CI, 59.9â65.0]). A greater proportion of patients underwent ventilation/perfusion scanning in larger hospitals compared with smaller hospitals (13.1% versus 7.3%, P <0.001). The use of computed tomography pulmonary angiography varied between 13.3% and 98.3% across the countries, and its use increased over time (46.5% in 2002 to 91.7% in 2018, P <0.001). Conclusions: In a large multinational PE registry, variations were observed in the use of imaging modalities according to patient or institutional factors and over time. However, computed tomography pulmonary angiography was the dominant modality of diagnosis, even in pregnancy and severe renal insufficiency. The safety, costs, and downstream effects of these tests on PE-related and non-PE-related outcomes warrant further investigation
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry
International audienceImportance: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, thrombosis in infrapopliteal veins without proximal extension or pulmonary embolism (PE).Objective: To determine the clinical characteristics, short-term, and 1-year outcomes in patients with IDDVT and to compare the outcomes in unadjusted and multivariable adjusted analyses with patients who had proximal DVT.Design, setting, and participants: This was a multicenter, international cohort study in participating sites of the Registro Informatizado Enfermedad TromboembĂłlica (RIETE) registry conducted from March 1, 2001, through February 28, 2021. Patients included in this study had IDDVT. Patients with proximal DVT were identified for comparison. Patients were excluded if they had a history of asymptomatic DVT, upper-extremity DVT, coexisting PE, or COVID-19 infection.Main outcomes and measures: Primary outcomes were 90-day and 1-year mortality, 1-year major bleeding, and 1-year venous thromboembolism (VTE) deterioration, which was defined as subsequent development of proximal DVT or PE.Results: A total of 33 897 patients were identified with isolated DVT (without concomitant PE); 5938 (17.5%) had IDDVT (mean [SD] age, 61 [17] years; 2975 male patients [50.1%]), and 27 959 (82.5%) had proximal DVT (mean [SD] age, 65 [18] years; 14 315 male patients [51.2%]). Compared with individuals with proximal DVT, those with IDDVT had a lower comorbidity burden but were more likely to have had recent surgery or to have received hormonal therapy. Patients with IDDVT had lower risk of 90-day mortality compared with those with proximal DVT (odds ratio [OR], 0.47; 95% CI, 0.40-0.55). Findings were similar in 1-year unadjusted analyses (hazard ratio [HR], 0.52; 95% CI, 0.46-0.59) and adjusted analyses (HR, 0.72; 95% CI, 0.64-0.82). Patients with IDDVT had a lower 1-year hazard of VTE deterioration (HR, 0.83; 95% CI, 0.69-0.99). In 1-year adjusted analyses of patients without an adverse event within the first 3 months, IDDVT was associated with lower risk of VTE deterioration (adjusted HR, 0.48; 95% CI, 0.24-0.97). By 1-year follow-up, symptoms or signs of postthrombotic syndrome were less common in patients with IDDVT (47.6% vs 60.5%).Conclusions and relevance: Results of this cohort study suggest that patients with IDDVT had a less ominous prognosis compared with patients with proximal DVT. Such differences were likely multifactorial, including the differences in demographics, risk factors, comorbidities, particularly for all-cause mortality, and a potential association of thrombus location with VTE deterioration and postthrombotic syndrome. Randomized clinical trials are needed to assess the optimal long-term management of IDDVT